Correlation Between Seer and Neurocrine Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Seer and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seer and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seer Inc and Neurocrine Biosciences, you can compare the effects of market volatilities on Seer and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seer with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seer and Neurocrine Biosciences.

Diversification Opportunities for Seer and Neurocrine Biosciences

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Seer and Neurocrine is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Seer Inc and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Seer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seer Inc are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Seer i.e., Seer and Neurocrine Biosciences go up and down completely randomly.

Pair Corralation between Seer and Neurocrine Biosciences

Given the investment horizon of 90 days Seer Inc is expected to under-perform the Neurocrine Biosciences. In addition to that, Seer is 2.41 times more volatile than Neurocrine Biosciences. It trades about -0.01 of its total potential returns per unit of risk. Neurocrine Biosciences is currently generating about 0.04 per unit of volatility. If you would invest  10,829  in Neurocrine Biosciences on October 21, 2024 and sell it today you would earn a total of  3,497  from holding Neurocrine Biosciences or generate 32.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Seer Inc  vs.  Neurocrine Biosciences

 Performance 
       Timeline  
Seer Inc 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Seer Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady technical and fundamental indicators, Seer reported solid returns over the last few months and may actually be approaching a breakup point.
Neurocrine Biosciences 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Seer and Neurocrine Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Seer and Neurocrine Biosciences

The main advantage of trading using opposite Seer and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seer position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.
The idea behind Seer Inc and Neurocrine Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
CEOs Directory
Screen CEOs from public companies around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.